Related Experiment Video
Updated: Aug 17, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Unusual cerebellar ataxia: "worm wobble" revisited
Insights
A 2-year-old girl developed cerebellar ataxia after piperazine citrate treatment for worms. This case highlights delayed neurotoxicity as a potential risk of piperazine therapy in children.
Area of Science:
- Pediatric Neurology
- Clinical Toxicology
Background:
- Piperazine citrate is a common anthelmintic medication used to treat parasitic worm infections.
- Neurotoxicity is a rare but serious adverse effect associated with certain medications.
Observation:
- A 2-year-old previously healthy female child presented with symptoms of cerebellar ataxia.
- The onset of ataxia occurred several days after receiving piperazine citrate for suspected helminthiasis.
Findings:
- This case represents the first documented instance of delayed-onset neurotoxicity following piperazine citrate administration.
- Cerebellar ataxia was the primary neurological manifestation observed.
Implications:
- Clinicians should be aware of the potential for delayed neurotoxicity with piperazine citrate, even in young children.
- Further investigation into the mechanisms of piperazine-induced neurotoxicity may be warranted.
Abstract:
We present an unusual case of cerebellar ataxia in a 2 year old girl several days after treatment with piperazine citrate for suspected worm infestation. This is the first reported case of delayed onset neurotoxicity following the therapeutic administration of piperazine in a previously well child.
Related Concept Videos
Gyroscope: Precession
Eccentric Axial Loading in a Plane of Symmetry
Eccentric Loading

